ArticleClinical ophthalmology (Auckland, N.Z.)2026
Home-Based Visual Field Monitoring for Open-Angle Glaucoma Using a Web-Enabled Quantitative Perimeter (Perimouse): An Evaluation Over Six Months.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the reliability and acceptability of home-based visual field monitoring in glaucoma patients using a self-developed online perimeter (Perimouse). Patients and Methods: In this prospective study, patients with stable open-angle glaucoma conducted monthly remote visual field tests using the Perimouse threshold program in an unsupervised home setting over six months, with Humphrey Field Analyzer (HFA) tests performed before and after the trial. The study evaluated patient compliance with Perimouse and compared its stability and variability to HFA. Additionally, a questionnaire assessed patient acceptability of Perimouse. Results: Sixty glaucoma patients (97 eyes) participated in this study. The follow-up completion rate of home tests remained 67.01% in the sixth month despite a gradual decline over time. A pointwise analysis demonstrated overall consistency, although variability increased as sensitivity decreased. Bland-Altman analysis of Perimouse mean deviation (MD) showed that the mean differences between Month 1 and Months 2-6 were close to zero. The mean absolute error for Perimouse MD ranged from 0.71 to 1.04, compared to 0.55 for HFA. Perimouse test duration decreased over six months, from 10.04 ± 2.74 minutes to 8.31 ± 2.77 minutes. The questionnaire indicated that Perimouse scoring higher than HFA in stress relief, visual comfort, and cost-effectiveness (P<0.05). Conclusion: This study showed that participants could perform Perimouse remotely in an unsupervised setting with video and written instructions. Perimouse may support home-based visual field monitoring and enhance self-management for glaucoma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.